Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation.
Company Details
- Employees
- 32
- Address
- 5857 Owens Avenue,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.qlgntx.com
- Keywords
- Representative jobs.
- HQ
- Carlsbad, CA
Qualigen Therapeutics Questions
Qualigen Therapeutics's website is http://www.qlgntx.com
Qualigen Therapeutics's LinkedIn profile is https://www.linkedin.com/company/qualigentherapeutics
Qualigen Therapeutics has
32 employees.
View email and phone details for 32
employees at Qualigen Therapeutics.
Qualigen Therapeutics's industry is
Biotechnology Research
Qualigen Therapeutics's top competitors are
Nanosynex,
Sandu Pharmaceuticals Ltd.,
Procisedx,
Kopran Ltd,
Endpoint Clinical,
Cue Health,
Ispecimen,
Geron Corporation,
Palisade Bio,
Qualigens Pharma Private Limited.
Qualigen Therapeutics's categories are Biotechnology Research
